Drug Delivery: Advances in drug delivery vehicles and devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Drug Delivery
Tablets & capsules, liquid-dosage forms. Inhalables & intranasals. Injectables: intravenous, intramuscular & subcutaneous. Nanotechnology, dissolvable films and tablets & radio frequency transdermal drug delivery.
Receive Content Alerts For:
Drug Delivery

Week of July 26, 2010: Company and People Notes: Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

July 29, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

Microneedles Boost Vaccine Efficacy

July 23, 2010

Pharmaceutical Technology Europe

Researchers claim that a dissolving microneedle patch may be able to offer improved vaccination against influenza compared with traditional needles, and also allow people without medical training to easily and safely administer the vaccine.

Week of July 19, 2010: Company and People Notes: Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

July 22, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

Seeking a Dissolution-Test Solution for Inhaled Drugs

July 21, 2010

Equipment and Processing Report

The pharmaceutical industry?s increasing interest in inhaled drugs has prompted several researchers to propose standard dissolution-testing methods for these products.

Week of July 12, 2010: Company and People Notes: Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

July 15, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

Week of July 5, 2010: Company and People Notes: Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

July 8, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.

A Word to the Unwise

July 2, 2010

Pharmaceutical Technology

After a spate of industrial disasters, the public seeks greater oversight of corporations—so does FDA.

Exploring the Tools in Nanoparticle Analysis

July 2, 2010

Pharmaceutical Technology

Nanotechnology is an important area of drug and biomedical research, and advancing nano-analysis is crucial for its further development.

Novel Suppository Design for HIV Chemoprophylaxis

July 2, 2010

Pharmaceutical Technology

Technical Note: The authors investigated the variables important for calcium-alginate formation as well as dissolution.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is your main concern regarding the outsourcing of various services to emerging countries?
Safety and quality issues
Lack of regulation
Job losses in the West
The distance
I have no concerns
Safety and quality issues
34%
Lack of regulation
24%
Job losses in the West
14%
The distance
3%
I have no concerns
24%
View Results
Jim MillerOutsourcing OutlookJim Miller Be Careful for What You Wish
Patricia Van ArnumIngredients InsiderPatricia Van ArnumAugmenting Excipient Functionality
Faiz kermaniSpotlight Faiz Kermani Reducing the number of failures in early stage development
Faiz kermaniStatistical Solutions Lynn D. TorbeckOn the Verge of Significance: Why 5%?
FindPharma Custom Search
Click here